Khoo SH, FitzGerald R, Saunders G, Middleton C, et al. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Infect Dis 2022 Oct 19. pii: S1473-3099(22)00644.
PMID: 36272432